SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) announced that it has filed two patent infringement suits in Europe. The patents asserted use cell-free fetal DNA for non-invasive prenatal testing (NIPT). The first suit was filed against The Doctors Laboratory Ltd, TDL Genetics Ltd, and Ariosa Diagnostics, Inc. in the High Court of Justice, Chancery Division […]

WILLOUGHBY, OH and SALEM, NH – Alpha Imaging, one of the largest independent sales and service providers of advanced medical imaging equipment, announced that it has executed a distribution agreement with Gamma Medica, Inc. The agreement covers distribution of Gamma Medica’s LumaGEM Molecular Breast Imaging solution in the Midwest and Mid-Atlantic regions. Molecular Breast Imaging […]

NEW YORK, NY – Enzo Biochem Inc. (NYSE:ENZ) announced the results of its Annual Shareholders Meeting today and updated shareholders on its businesses. Shareholders voted overwhelmingly to re-elect the Company’s nominees, Gregory M. Bortz and Dov Perlysky, as Class I directors to hold office for a term of three years. Shareholders also ratified the selection […]

bioMérieux, a world leader in the field of in vitro diagnostics, today announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data. Since it was founded in 1992, the company has gained worldwide recognition by leveraging its strong […]

MILFORD, Mass. — Waters Corporation (NYSE: WAT) today announced that the Waters® ACQUITY UPLC® I-Class IVD/Xevo® TQ-S micro IVD System is now manufactured as a U.S. FDA Class I medical device and is CE Marked to the European Directive 98/79/EC (IVDD). This development allows clinical laboratories to access leading innovations in liquid chromatography (LC) and […]

Oxford, UK: Genomics plc (“Genomics”), a leading analysis company developing algorithms, data resources, and software solutions to uncover the relationships between genetic variation and human disease, today announced that Vertex Pharmaceuticals will use Genomics’ integrated database and state-of-the-art analysis tools to inform its drug research and development. These tools aim to provide confidence in the […]

OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced that it has been awarded a two-year Small Business Technology Transfer (STTR) grant by the US National Institutes of Health (NIH). The $1.5 million grant will fund a collaborative project […]

NORCROSS, Ga. – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, in collaboration with Sirona Genomics, announced the launch of MIA FORA NGS, a high resolution HLA typing solution that provides accurate, comprehensive coverage of 11 HLA genes. With an efficient workflow that can be uniquely automated or run manually, MIA FORA NGS […]

South Plainfield, NJ –– Leading global genomics service provider, GENEWIZ, has signed a definitive agreement to acquire the genomic services business of Beckman Coulter, which delivers expert genomics sequencing solutions to healthcare businesses, as well as academic and government institutions worldwide (GS). “The genomic services business of Beckman Coulter is an ideal fit with GENEWIZ’s […]

The advent of Next Generation Sequencing (NGS) has revolutionised rare disease genomic research, to improve diagnosis and discover novel causative genes. UCB, a global biopharmaceutical leader, is harnessing these advances to unpick the mechanisms behind novel rare diseases as a means for better understanding fundamental biological processes. UCB’s goal is to transform this insight into […]